US EditionLife Sciences Company 180 Pivots to Ethereum Strategy with $425M Funding Round
Summary by Blockhead
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Life Sciences Company 180 Pivots to Ethereum Strategy with $425M Funding Round
180 Life Sciences Corp., a Nasdaq-listed biotechnology company trading under the ticker ATNF, has announced a business pivot toward cryptocurrency with a $425 million private placement aimed at building an Ethereum treasury strategy and rebranding as ETHZilla Corporation.The transaction represents one of the largest corporate pivots from traditional sectors into digital assets, with 180 Life Sciences planning to use proceeds primarily for purcha…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
